主要成分是Liraglutide 3 mg的Saxenda善纖達，是一種GLP-1 類似物，屬天然荷爾蒙，會因進食而釋放，作用於下視丘，在此處與食慾和食物攝取調節有關的特定神經元進行交互作用，能夠讓人產生飽足感、抑制食慾，減緩胃部排空的速度進而使人減少食物攝取量，來達到減重的效果。且許多人對口服藥物有困難，Saxenda善纖達便成了很棒的替代方案。
Saxenda善纖達已通過台灣衛福部核准，適用於體重控制，做為低熱量飲食及增加體能活動外之輔助療法，適用對象為成人且初始身體質量指數(BMI)為 ≥30 kg/m²，或 ≥27 kg/m² 至 <30 kg/m²，且至少有一項體重相關共病，例如第二型糖尿病、高血壓或血脂異常。劑量須遵照醫囑循序漸進的使用，才不會有頭暈、噁心的不適反應。
The main ingredient is Liraglutide 3 mg of Saxenda, a GLP-1 analog, a natural hormone that is released in response to eating and acts on the hypothalamus, where it interacts with specific neurons involved in the regulation of appetite and food intake , can make people feel full, suppress appetite, slow down the speed of gastric emptying and then reduce food intake, so as to achieve the effect of weight loss. And with many people having difficulty taking oral medications, Saxenda is a great alternative.
Saxenda has been approved by the Ministry of Health and Welfare of Taiwan, suitable for weight control, as an adjuvant therapy in addition to low-calorie diet and increased physical activity, suitable for adults with an initial body mass index (BMI) ≥ 30 kg/m², or ≥ 27 kg /m² to <30 kg/m² with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or dyslipidemia. The dose must be used step by step according to the doctor’s advice, so as not to cause dizziness and nausea discomfort.